These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20446070)

  • 21. Current and potential urological applications of botulinum toxin A.
    Jiang YH; Liao CH; Kuo HC
    Nat Rev Urol; 2015 Sep; 12(9):519-33. PubMed ID: 26260879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin type A for refractory post-stroke shoulder pain.
    Pedreira G; Cardoso E; Melo A
    Arq Neuropsiquiatr; 2008 Jun; 66(2A):213-5. PubMed ID: 18545785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The therapeutic potential of botulinum toxin.
    Klein AW
    Dermatol Surg; 2004 Mar; 30(3):452-5. PubMed ID: 15008883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type A therapy in chronic pain disorders.
    Lang AM
    Arch Phys Med Rehabil; 2003 Mar; 84(3 Suppl 1):S69-73; quiz S74-5. PubMed ID: 12708561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.
    Porta M
    Pain; 2000 Mar; 85(1-2):101-5. PubMed ID: 10692608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Botulinum toxin A in orthopedic pain therapy].
    Placzek R; Söhling M; Gessler M; Jerosch J
    Schmerz; 2004 Dec; 18(6):498-505. PubMed ID: 15586299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraprostatic injection of botulinum toxin-A in patients with refractory chronic pelvic pain syndrome: The transurethral vs. transrectal approach.
    El-Enen MA; Abou-Farha M; El-Abd A; El-Tatawy H; Tawfik A; El-Abd S; Rashed M; El-Sharaby M
    Arab J Urol; 2015 Jun; 13(2):94-9. PubMed ID: 26413328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botox treatment in patients with chronic functional anorectal pain: experiences of a tertiary referral proctology clinic.
    Ooijevaar RE; Felt-Bersma RJF; Han-Geurts IJ; van Reijn D; Vollebregt PF; Molenaar CBH
    Tech Coloproctol; 2019 Mar; 23(3):239-244. PubMed ID: 30778784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
    Abbott JA; Jarvis SK; Lyons SD; Thomson A; Vancaille TG
    Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.
    Bohluli B; Motamedi MH; Bagheri SC; Bayat M; Lassemi E; Navi F; Moharamnejad N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan; 111(1):47-50. PubMed ID: 20674409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin type A (BOTOX) for treatment of migraine.
    Binder WJ; Brin MF; Blitzer A; Pogoda JM
    Dis Mon; 2002 May; 48(5):323-35. PubMed ID: 12195263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of intra-articular injection of botulinum toxin type A in refractory hemiplegic shoulder pain.
    Castiglione A; Bagnato S; Boccagni C; Romano MC; Galardi G
    Arch Phys Med Rehabil; 2011 Jul; 92(7):1034-7. PubMed ID: 21704782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.
    Chancellor MB; Fowler CJ; Apostolidis A; de Groat WC; Smith CP; Somogyi GT; Aoki KR
    Nat Clin Pract Urol; 2008 Jun; 5(6):319-28. PubMed ID: 18461049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence-based approach of the use of Botulinum toxin type A (BTX) in cerebral palsy.
    Wong V
    Pediatr Rehabil; 2003; 6(2):85-96. PubMed ID: 14534045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
    Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
    Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot study of botulinum toxin for interstitial cystitis/painful bladder syndrome.
    Gottsch HP; Miller JL; Yang CC; Berger RE
    Neurourol Urodyn; 2011 Jan; 30(1):93-6. PubMed ID: 20589903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis.
    Jhang JF; Jiang YH; Kuo HC
    Int J Urol; 2014 Apr; 21 Suppl 1():49-55. PubMed ID: 24807497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.